| Concentration: |
| ~1mg/ml |
| Immunogen: |
| Japanese Encephalitis Virus, Nakayama strain. |
| Purity: |
| Purified |
| Form |
| Supplied as a liquid in 0.02M PBS, pH7.6, 0.25M sodium chloride, 0.1% sodium azide. |
| Specificity: |
| Recognizes epitope E-8 on the E protein of Japanese Encephalitis Virus (Nakayama). Crossreactivity: St. Louis encephalitis (MSI-7), West Nile (EG 101) and Murray Valley encephalitis. Does not crossreact with Yellow Fever or Dengue Virus. |
|
| Intended for research use only. Not for use in human, therapeutic, or diagnostic applications. |
1. Arunachalam, N., et al., (2004), “Japanese encephalitis in Kerala, south India: can Mansonia (Diptera: Culicidae) play a supplemental role in Transmission?”, J. Med. Entomol., 41: 456-461. 2. Rajendran, R., et al., (2003), “Longitudinal studies in South Indian villages on Japanese encephalitis virus infection in mosquitoes and seroconversion in goats”, Trop. Med. Int. Health, 8: 174-181. 3. Roehrig, J.T., et al., (2001), “Antibody phophylaxis and therapy for flavivirus encephalitis infections”, In West Nile Virus: Detection, Surveillance and Controls, Eds., D.J. White and D.L. Morse, New York , Acad. Sci., New York, NY., 286-297. 4. Pike, A., et al., (2001), “The appearance of a second genotype of Japanese Encephalitis Virus in the Australasian region”, Am. J. Trop. Med. Hyg., 65: 747-753. |
|